Health
London: Oxford University’s AstraZeneca vaccine candidate, AZD1222, which is being developed against COVID-19 disease has shown 70 percent efficiency on average, officials said. more
Oxford University's COVID-19 vaccine triggers 'strong immune response'
London: Setting a big mark of progress, a coronavirus vaccine developed by the University of Oxford has produced a strong immune response and appeared to be safe, a new study revealed on ...
